Anticoagulant Coatings for Interventional Devices

Based on the different nature of friction, the tribological problems involved in cardiovascular devices can be mainly summarized into the following three categories:

1. Mechanical friction and wear generated by moving parts inside the device;

2. Fluid friction caused by blood flow across the device surface;

3. Interfacial friction between the device and human soft tissue during implantation or normal function.

Among these, fluid friction generated by blood flow on the implant surface may activate abnormal coagulation mechanisms and induce thrombosis, posing a significant challenge to the design and application of cardiovascular devices.

Regarding the coagulation response caused by contact between the implant surface and blood, current anticoagulation strategies are mainly divided into two categories: one is to block the coagulation pathway, and the other is to promote the normalization of the function of tissues surrounding the device.

Blocking the Coagulation Pathway

This strategy is mainly achieved through surface coating technology, including drug-eluting coatings and bio-inert coatings. Drug-eluting coatings fix anticoagulant drugs on the device surface, directly regulating the coagulation and complement systems and reducing inflammatory responses; bio-inert coatings inhibit blood activation processes by reducing the interaction between the surface and blood components.

Commonly used anticoagulants include heparin, thrombomodulin, and hirudin. Heparin, a key anticoagulant, binds to antithrombin through its pentasaccharide sequence, significantly enhancing its inhibitory efficiency on coagulation factors. Thrombomomodulin, on the other hand, activates protein C, inactivating key coagulation factors and thus blocking thrombin formation.

Bioinert coatings encompass both organic and inorganic types. For example, albumin coatings effectively reduce fibrin adhesion and platelet activation; polyethylene glycol constructs linear polymer brushes to repel protein adsorption; zwitterionic materials, such as phosphorylcholine-containing polymers, significantly inhibit protein adhesion and platelet activation. Furthermore, while polydopamine does not directly inhibit coagulation, it possesses good biocompatibility and surface adaptability. Inspired by nature, liquid-injected porous surface technology achieves blood component repulsion and surface self-repair by immobilizing perfluorocarbon liquid.

In inorganic inert coatings, carbon-based materials such as diamond-like carbon and pyrolytic carbon are widely used in ventricular assist devices and heart valves due to their hydrophobicity, smoothness, and good biocompatibility.

Promoting the Normalization of Peri-Device Tissue Function

This strategy aims to mimic the natural structure and function of vascular endothelium to improve blood compatibility.

For example, pre-seeding endothelial cells on the device surface can effectively inhibit thrombus formation and intimal hyperplasia. The discovery of endothelial progenitor cells has further promoted the development of rapid self-endothelialization. In addition, extracellular matrix components such as fibronectin and collagen, as well as specific factors such as CD34 antibodies, are also used to guide endothelial cell adhesion and proliferation. Titanium dioxide coatings also show the potential to promote endothelial cell behavior.

Ultrasonic spraying technology is demonstrating significant advantages in the preparation of anticoagulant coatings for implantable medical devices (such as vascular stents and artificial heart valves). Compared with traditional spraying, it utilizes high-frequency acoustic energy to break the drug solution into micron-sized uniform droplets, achieving precise and controllable coating application.

This technology ensures the formation of an ultra-thin, uniform, and dense film of anticoagulants (such as heparin) on the complex surfaces of medical devices, significantly improving coating consistency and quality. This not only effectively enhances the biocompatibility and anticoagulant efficacy of the devices but also significantly reduces the amount of expensive drugs used, saving production costs.

Furthermore, the “soft mist” characteristic of ultrasonic spraying avoids potential damage to the coating structure and drug activity caused by high pressure, ensuring efficacy. Its highly automated process also ensures batch-to-batch stability and repeatability, fully complying with the stringent GMP production requirements for medical devices.

In conclusion, ultrasonic spraying provides an efficient, precise, and economical ideal solution for the preparation of high-performance anticoagulant coatings for implantable medical devices, and is an important process driving the development of high-end medical devices.

About Cheersonic

Cheersonic is the leading developer and manufacturer of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive.

Our coating solutions are environmentally-friendly, efficient and highly reliable, and enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

If you have any technical questions, customization demands, or procurement inquiries about ultrasonic atomization nozzles, feel free to contact our professional sales and technical team for detailed parameters, customized solutions, and industry application support.
Email: market2@cheersonic.com